Back
MercadoLibre 10K Form
Sell
35
MELI
MercadoLibre
Last Price:
1,395.04
Seasonality Move:
7.75%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2023-11-02 | 10Q | MELI/MercadoLibre Quarterly |
2023-08-03 | 10Q | MELI/MercadoLibre Quarterly |
2023-05-04 | 10Q | MELI/MercadoLibre Quarterly |
2022-11-04 | 10Q | MELI/MercadoLibre Quarterly |
2022-08-04 | 10Q | MELI/MercadoLibre Quarterly |
2022-05-06 | 10Q | MELI/MercadoLibre Quarterly |
Receive MELI News And Ratings
See the #1 stock for the next 7 days that we like better than MELI
MELI Financial Statistics
Sales & Book Value
Annual Sales: | $14.47B |
---|---|
Cash Flow: | $1.75B |
Price / Cash Flow: | 15.2 |
Annual Sales: | $60.58 |
Price / Book: | 22.61 |
Profitability
EPS (TTM): | 19.54000 |
---|---|
Net Income (TTM): | $987M |
Gross Margin: | $7.21B |
Return on Equity: | 41.36% |
Return on Assets: | 6.41% |
MercadoLibre Earnings Forecast
Key MercadoLibre Financial Ratios
- The Gross Profit Margin over the past 22 years for MELI is 49.79%.
- The Selling, General & Administrative Expenses for MELI have been equal to 17.29% of Gross Profit Margin.
- The Research & Development expenses have been 12.65% of Revenue.
- The Interest Expense is 38.30% of Operating Income.
- The Net Earning history of MELI is 6.82% of Total Revenues.
- Per Share Earnings over the last 22 years have been positive in 15 years.
MercadoLibre Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Broadline Retail |
Sector: | Consumer Discretionary |
Current Symbol: | MELI |
CUSIP: | 58733R |
Website: | mercadolibre.com |
Debt
Debt-to-Equity Ratio: | 1.42 |
---|---|
Current Ratio: | 1.27 |
Quick Ratio: | 0.91 |
Price-to-Earnings
Trailing P/E Ratio: | 70.38 |
---|---|
Forward P/E Ratio: | 30.69 |
MELI Technical Analysis vs Fundamental Analysis
Sell
35
MercadoLibre (MELI)
is a Sell
Is MercadoLibre a Buy or a Sell?
-
MercadoLibre stock is rated a Sell
The current MercadoLibre [MELI] share price is $1,369.59. The Score for MELI is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.